A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
Abstract
Pharmacotherapeutic options for multiple sclerosis (MS)-related fatigue are limited. Thirty patients were randomly assigned to aspirin (ASA) 1,300 mg/day or placebo in a double-blind crossover study. Results favored ASA for the main clinical outcomes: Modified Fatigue Impact Scale scores (p = 0.043) and treatment preference (p = 0.012). There were no significant adverse effects. The results warrant further study and support a role for ASA-influenced mechanisms, perhaps immunologic, in the generation of MS-related chronic fatigue.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
File (wingerchuk.pdf)
- Download
- 66.93 KB
References
1.
Multiple Sclerosis Clinical Practice Guidelines: Fatigue and Multiple Sclerosis: Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis. Washington, DC: Paralyzed Veterans Association, 1998.
2.
Brañas P, Jordan R, Fry-Smith A, Burls A, Hyde C. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess 2000;4:1–61.
3.
Wingerchuk DM, Benarroch E, Rodriguez M. Aspirin for multiple sclerosis related fatigue. Can J Neurol Sci 1997;24:161.
4.
Senn, S. Cross-over trials in clinical research. West Sussex, England: John Wiley and Sons Ltd., 1993.
5.
Wingerchuk DM, Noseworthy JH, Weinshenker BG. Clinical outcome measures and rating scales in multiple sclerosis trials. Mayo Clin Proc 1997;72:1070–1079.
6.
Amin AR, Attur MG, Pillinger M, Abramson SB. The pleiotropic functions of aspirin: mechanisms of action. Cell Mol Life Sci 1999;56:305–312.
7.
Conti B, Tabarean I, Andrei C, Bartfai T. Cytokines and fever. Front Biosci 2004;9:1433–1449.
8.
Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000;321:1183–1187.
9.
Schwid SR, Thornton CA, Pandya S, et al. Quantitative assessment of motor fatigue and strength in MS. Neurology 1999;53:743–750.
10.
Krupp LB, Elkins LE. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000;55:934–939.
Information & Authors
Information
Published In
Copyright
© 2005.
Publication History
Published online: April 11, 2005
Published in print: April 12, 2005
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Assessment of acupuncture's effectiveness in mitigating fatigue among patients afflicted with multiple sclerosis: A systematic review and meta-analysis, Complementary Therapies in Clinical Practice, 57, (101902), (2024).https://doi.org/10.1016/j.ctcp.2024.101902
- A randomized controlled trial of oral antipyretic treatment to reduce overheating during exercise in adults with multiple sclerosis, Journal of Neurology, 271, 5, (2207-2215), (2024).https://doi.org/10.1007/s00415-023-12147-6
- The neuroimmunology of fatigue in multiple sclerosis, Translational Neuroimmunology, Volume 8, (55-72), (2023).https://doi.org/10.1016/B978-0-443-18578-6.00004-0
- Multiple sclerosis-related fatigue lacks a unified definition, Journal of Research in Medical Sciences, 27, 1, (24), (2022).https://doi.org/10.4103/jrms.jrms_1401_20
- A Systematic Review on the Role of Arachidonic Acid Pathway in Multiple Sclerosis, CNS & Neurological Disorders - Drug Targets, 21, 2, (160-187), (2022).https://doi.org/10.2174/1871527319666200825164123
- Opportunities for Molecular Imaging in Multiple Sclerosis Management: Linking Probe to Treatment, Radiology, 303, 3, (486-497), (2022).https://doi.org/10.1148/radiol.211252
- Literatur, Multiple Sklerose, (468-512), (2022).https://doi.org/10.1016/B978-3-437-22085-2.00028-8
- Drug Treatment of Psychiatric Symptoms Occurring in the Context of Other Disorders, The Maudsley Prescribing Guidelines in Psychiatry, (777-830), (2021).https://doi.org/10.1002/9781119870203.mpg010
- Efficacy and Safety of Amantadine for the Treatment of Fatigue in Multiple Sclerosis: A Systematic Review and meta-analysis, Neurodegenerative Disease Management, 10, 6, (383-395), (2020).https://doi.org/10.2217/nmt-2020-0030
- ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis, BMJ Open, 10, 11, (e039691), (2020).https://doi.org/10.1136/bmjopen-2020-039691
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.